Online education and tutoring in general is a vastly profitable market, especially in the wake of the COVID-19 pandemic. Moreover, if there is one area in particular where online education and tutoring possesses especially large business opportunities with even greater growth potential, it is China.

While the list of those garnering the most attention read like the usual suspects, there’s probably one biotech firm you haven’t heard of, VBI Vaccines (NASDAQ:VBIV). While VBIV stock soared to multi-year highs around mid-July, shares have found themselves plummeting back to earth. As several now well-known vaccine companies have entered into late-stage clinical trials for their Covid-19 candidates, the other, smaller names have lost their luster.

QEBR (OTC Pink: QEBR) has 300 machines configured to engage the Filecoin (FIL) network. Based on internal estimates, each machine has the possibility to mine 358 Filecoin reward tokens per month. At an expected price of $22.52 per coin, QEBR, assuming no changes to the hardware count, could generate nearly $2.42 million in revenue per month.

US media hasn’t picked up on the linkage to DELL and INTC. The potential of a 20 second COVID-19 test is “priceless”. The existence of this test allows governments to loosen social distancing restrictions as they get used at schools, universities, airports, hospitals, sporting events...the list is endless!

It is very rare for a stock to command a 100% premium in what amounts to a secondary offering unless there is...